1. CTIM-26. PHASE II TRIAL OF SURVAXM PLUS TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA. (14th November 2022) Authors: Ahluwalia, Manmeet; Ciesielski, Michael J; Reardon, David A; Abad, Ajay; Curry, William; Wong, Eric; Peereboom, David; Figel, Sheila; Hutson, Alan; Groman, Adrienne; Withers, Henry; Liu, Song; Belal, Ahmed; Qiu, Jingxin; Mogensen, Kathleen; Schilero, Cathy; Khosla, Atulya; Casucci, Danielle; Mech... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗